德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06996 德琪医药-B

开市前 06-08 09:22:54

1.830

+0.000

0.00%

最高1.830	最低1.830	成交量0.00
今开1.830	昨收1.830	日振幅0.00%
总市值12.35亿	流通市值12.35亿	总股本6.75亿
成交额0.00	换手率0.00%	流通股本6.75亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06996","market":"HK","secType":"STK","nameCN":"德琪医药-B","latestPrice":1.83,"timestamp":1686186002175,"preClose":1.83,"halted":0,"volume":0,"delay":0,"floatShares":674888744,"shares":674888744,"eps":-1.0677849,"marketStatus":"开市前","marketStatusCode":1,"change":0,"latestTime":"06-08 09:22:54","open":1.83,"high":1.83,"low":1.83,"amount":0,"amplitude":0,"askPrice":1.91,"askSize":500,"bidPrice":1.81,"bidSize":7500,"shortable":3,"etf":0,"ttmEps":-1.0677849511617696,"exchange":"SEHK","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1686187800000},"adr":0,"listingDate":1605801600000,"adjPreClose":1.83,"volumeRatio":0,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06996","defaultTab":"news","newsList":[{"id":"2341013293","title":"德琪医药-B尾盘涨超4% 希维奥®获澳大利亚药品福利计划收录","url":"https://stock-news.laohu8.com/highlight/detail?id=2341013293","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2341013293?lang=zh_CN&edition=full","pubTime":"2023-06-05 12:00","pubTimestamp":1685937600,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　德琪医药-B（06996）尾盘上涨4.37%，现报1.91港元，成交额94.199万港元，总市值13.09亿港元。\n　　近日，德琪医药宣布，希维奥®（通用名：塞利尼索片，英文商品名：XPOVIO®）联合硼替佐米及地塞米松塞（XVd方案）获澳大利亚药品福利计划（PBS）收录，用于治疗接受过至少一种既往治疗的R/R MM成人患者。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/tob/2023-06-05/doc-imywfaue8635951.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2023-06-05/doc-imywfaue8635951.shtml","is_publish_highlight":false},{"id":"2341013576","title":"港股异动 | 德琪医药-B(06996)午前涨超6% 希维奥®又一方案纳入澳大利亚药品福利计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2341013576","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2341013576?lang=zh_CN&edition=full","pubTime":"2023-06-05 11:46","pubTimestamp":1685936812,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德琪医药-B(06996)午前涨超6%。截至发稿，涨6.01%，报1.94港元，总市值13.09亿港元。消息面上，德琪医药近日宣布，希维奥®（通用名：塞利尼索片，英文商品名：XPOVIO®）联合硼替佐米及地塞米松塞（XVd方案）获澳大利亚药品福利计划（PBS）收录，用于治疗接受过至少一种既往治疗的R/R MM成人患者。III期BOSTON研究数据显示，XVd方案对于年轻、老年、虚弱、不虚弱以及存在肾功能不全的患者均有效。值得一提的是，XVd方案对于细胞遗传学状态为高危的患者尤为其有效。据悉，希维奥®联合地塞米松（Xd方案）曾于2022年9月获PBS收录。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/940463.html","is_publish_highlight":false},{"id":"2341092237","title":"德琪医药-B盘中异动 股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2341092237","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2341092237?lang=zh_CN&edition=full","pubTime":"2023-06-05 09:52","pubTimestamp":1685929935,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023060509521582cf3305&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023060509521582cf3305&s=b","is_publish_highlight":false},{"id":"2340768204","title":"德琪医药-B盘中异动 股价大涨5.52%报1.910港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2340768204","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2340768204?lang=zh_CN&edition=full","pubTime":"2023-06-02 10:15","pubTimestamp":1685672144,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023060210154482ce5efc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023060210154482ce5efc&s=b","is_publish_highlight":false},{"id":"2340233282","title":"德琪医药(6996.HK)：希维奥二线治疗方案获纳入澳大利亚药品福利计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2340233282","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2340233282?lang=zh_CN&edition=full","pubTime":"2023-06-01 10:02","pubTimestamp":1685584942,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-06-01/doc-imyvtwai9328362.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-06-01/doc-imyvtwai9328362.shtml","is_publish_highlight":false},{"id":"2339673622","title":"德琪医药-B盘中异动 早盘急速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2339673622","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2339673622?lang=zh_CN&edition=full","pubTime":"2023-05-31 10:45","pubTimestamp":1685501103,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305311045038472d9ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305311045038472d9ca&s=b","is_publish_highlight":false},{"id":"2337092460","title":"重磅！美国FDA接连授予德琪医药（6996.HK）Claudin 18.2抗体偶联药物两项孤儿药资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2337092460","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2337092460?lang=zh_CN&edition=full","pubTime":"2023-05-24 17:20","pubTimestamp":1684920030,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=8377bc9df6fef435e1f4efbe14cb4f03","is_publish_highlight":false},{"id":"2337934826","title":"德琪医药-B盘中异动 股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2337934826","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2337934826?lang=zh_CN&edition=full","pubTime":"2023-05-23 14:39","pubTimestamp":1684823976,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052314393682cb3153&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052314393682cb3153&s=b","is_publish_highlight":false},{"id":"2336324614","title":"FDA批准！德琪医药（6996.HK）ATG-031成为全球首个进入临床的抗CD24单抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2336324614","media":"权证网","top":-1,"share":"https://www.laohu8.com/m/news/2336324614?lang=zh_CN&edition=full","pubTime":"2023-05-18 09:38","pubTimestamp":1684373921,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051809384383c6d96f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051809384383c6d96f&s=b","is_publish_highlight":false},{"id":"2336230933","title":"德琪医药-B：ATG-031的I期药效试验获美国FDA的IND许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2336230933","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2336230933?lang=zh_CN&edition=full","pubTime":"2023-05-18 07:52","pubTimestamp":1684367552,"startTime":"0","endTime":"0","summary":"德琪医药-B（06996）发布公告，首款潜力的抗CD24单克隆抗体药物ATG-031的I期研究的临床研究用新药（IND）申请已获美国食品药品监督管理局（FDA）许可。\n　　药效试验是用于治疗晚期实体瘤或B细胞非霍奇金淋巴瘤（B-NHL）患者的ATG031首次人体、多中心、开放性I期剂量研究。该研究的主要目的是评估ATG-031作为单一疗法的安全性和耐受性，并确定II期研究的适当剂量。次要目的是列明其在药理学的特色、评估免疫原性及评估ATG-031的初步疗效（如可行）。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/tob/2023-05-18/doc-imyueakh8534075.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2023-05-18/doc-imyueakh8534075.shtml","is_publish_highlight":false},{"id":"2336340305","title":"德琪医药-B(06996.HK)：用于治疗晚期实体瘤或B-NHL患者的ATG-031的I期药效试验获美国FDA的IND许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2336340305","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2336340305?lang=zh_CN&edition=full","pubTime":"2023-05-18 06:34","pubTimestamp":1684362875,"startTime":"0","endTime":"0","summary":"来源：格隆汇格隆汇5月18日丨德琪医药-B(06996.HK)发布公告，首款潜力的抗CD24单克隆抗体药物ATG-031的I期研究的临床研究用新药(“IND”)申请已获美国食品药品监督管理局(“FDA”)许可。药效试验是用于治疗晚期实体瘤或B细胞非霍奇金淋巴瘤(B-NHL)患者的ATG031首次人体、多中心、开放性I期剂量研究。该研究的主要目的是评估ATG-031 作为单一疗法的安全性和耐受性，并确定II期研究的适当剂量。次要目的是列明其在药理学的特色、评估免疫原性及评估ATG-031的初步疗效(如可行)。 \n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-05-18/doc-imyucwai2625926.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-05-18/doc-imyucwai2625926.shtml","is_publish_highlight":false},{"id":"2336347434","title":"德琪医药-B(06996)：ATG-031的I期药效试验获美国FDA的IND许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2336347434","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2336347434?lang=zh_CN&edition=full","pubTime":"2023-05-18 06:13","pubTimestamp":1684361600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/932026.html","is_publish_highlight":false},{"id":"2336325627","title":"全球最权威创新药大会之一将召开，多家A股公司将亮相","url":"https://stock-news.laohu8.com/highlight/detail?id=2336325627","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2336325627?lang=zh_CN&edition=full","pubTime":"2023-05-17 16:04","pubTimestamp":1684310685,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051716031384719b65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051716031384719b65&s=b","is_publish_highlight":false},{"id":"2336361434","title":"喜讯！德琪医药希维奥在印度尼西亚的新药上市申请已成功递交","url":"https://stock-news.laohu8.com/highlight/detail?id=2336361434","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2336361434?lang=zh_CN&edition=full","pubTime":"2023-05-17 15:35","pubTimestamp":1684308919,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=06b89349281d06e92f1e26d0b0413b3b","is_publish_highlight":false},{"id":"2336936134","title":"喜讯！德琪医药（6996.HK）希维奥®（塞利尼索片）在印度尼西亚的新药上市申请已成功递交","url":"https://stock-news.laohu8.com/highlight/detail?id=2336936134","media":"权证网","top":-1,"share":"https://www.laohu8.com/m/news/2336936134?lang=zh_CN&edition=full","pubTime":"2023-05-17 14:57","pubTimestamp":1684306651,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051714573283c4b69f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051714573283c4b69f&s=b","is_publish_highlight":false},{"id":"2336046359","title":"德琪医药-B盘中异动 早盘大幅跳水6.54%报2.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2336046359","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2336046359?lang=zh_CN&edition=full","pubTime":"2023-05-17 10:48","pubTimestamp":1684291717,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051710483780658a26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051710483780658a26&s=b","is_publish_highlight":false},{"id":"2335525888","title":"德琪医药-B盘中异动 早盘股价大跌5.69%报2.321港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2335525888","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2335525888?lang=zh_CN&edition=full","pubTime":"2023-05-15 10:13","pubTimestamp":1684116805,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051510132582c8e6e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051510132582c8e6e1&s=b","is_publish_highlight":false},{"id":"2334506520","title":"德琪医药-B盘中异动 股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2334506520","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2334506520?lang=zh_CN&edition=full","pubTime":"2023-05-12 15:04","pubTimestamp":1683875052,"startTime":"0","endTime":"0","summary":"2023年05月12日下午盘15时04分，德琪医药-B股票出现异动，股价大幅下挫5.34%。截至发稿，该股报2.481港元/股，成交量151.25万股，换手率0.22%，振幅6.87%。德琪医药-B股票所在的药品行业中，整体涨幅为0.03%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051215041282c8770c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051215041282c8770c&s=b","is_publish_highlight":false},{"id":"2330598819","title":"德琪医药-B盘中异动 股价大涨5.59%报2.831港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2330598819","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2330598819?lang=zh_CN&edition=full","pubTime":"2023-04-28 09:38","pubTimestamp":1682645937,"startTime":"0","endTime":"0","summary":"2023年04月28日早盘09时38分，德琪医药-B股票出现波动，股价急速上涨5.59%。截至发稿，该股报2.831港元/股，成交量4000股，换手率0.00%，振幅3.36%。德琪医药-B股票所在的药品行业中，整体涨幅为0.11%。其相关个股中，康龙化成、顺腾国际控股、康臣药业涨幅较大，振幅较大的相关个股有山东新华制药股份、康哲药业、丽珠医药，振幅分别为4.86%、3.77%、3.38%。该公司主要在亚太地区开展业务。消息层面，截至09时38分，德琪医药-B股票正面舆情新闻比例69.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230428093857846fed38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230428093857846fed38&s=b","is_publish_highlight":false},{"id":"2330897733","title":"德琪医药-B盘中异动 早盘快速跳水5.05%报2.631港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2330897733","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2330897733?lang=zh_CN&edition=full","pubTime":"2023-04-25 09:57","pubTimestamp":1682387822,"startTime":"0","endTime":"0","summary":"2023年04月25日早盘09时57分，德琪医药-B股票出现异动，股价快速跳水5.05%。截至发稿，该股报2.631港元/股，成交量45.05万股，换手率0.07%，振幅3.97%。德琪医药-B股票所在的药品行业中，整体跌幅为0.54%。其相关个股中，兴科蓉医药、华控康泰、满贯集团涨幅较大，振幅较大的相关个股有山东新华制药股份、先声药业、华控康泰，振幅分别为9.76%、6.83%、6.82%。该公司主要在亚太地区开展业务。消息层面，截至09时57分，德琪医药-B股票正面舆情新闻比例28.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230425095703846f6d3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230425095703846f6d3c&s=b","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.3197},{"period":"3month","weight":-0.4554},{"period":"6month","weight":-0.6172},{"period":"1year","weight":-0.7451},{"period":"ytd","weight":-0.6447}],"websiteUrl":"http://www.antengene.com","compareEarnings":[{"period":"1week","weight":0.0558},{"period":"1month","weight":-0.0515},{"period":"3month","weight":-0.0338},{"period":"6month","weight":-0.0326},{"period":"1year","weight":-0.1059},{"period":"ytd","weight":-0.0268}],"name":"德琪医药-B","description":"德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要从事生物科技产品的发现、开发、生产及商业化。该公司的主要产品包括用于治疗复发╱难治性多发性骨髓瘤、复发╱难治性弥漫大B细胞淋巴瘤和非小细胞肺癌的ATG-010(selinexor)及用于治疗肝细胞癌和非小细胞肺癌等多种适应症的ATG-008(onatasertib)。该公司主要在亚太地区开展业务。","exchange":"SEHK","nameEN":"ANTENGENE-B","compareStock":{"symbol":"HSI","name":"恒生指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.13.0","shortVersion":"4.13.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德琪医药-B,06996,德琪医药-B股票,德琪医药-B股票老虎,德琪医药-B股票老虎国际,德琪医药-B行情,德琪医药-B股票行情,德琪医药-B股价,德琪医药-B股市,德琪医药-B股票价格,德琪医药-B股票交易,德琪医药-B股票购买,德琪医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}